Articles Tagged With:
-
Managing Pott’s Puffy Tumor and Sinogenic or Otogenic Intracranial Empyema
Following the COVID-19 pandemic, the incidence of sinogenic and otogenic intracranial empyemas increased. The author reviews the presentation, imaging, and treatment for this potentially life-threatening infection, with a reminder to keep this on your differential when evaluating your youngest patients.
-
Missouri Appellate Court Reverses Trial Court’s Grant of Summary Judgment After Finding that Injured Patient’s Evidence Could Show Medical Negligence of Chiropractor
In a medical negligence case, an appellate court in Missouri recently reversed a trial court’s grant of summary judgment to a chiropractor defendant on the basis that there were factual issues that should have been decided by the jury. After a patient sued her chiropractor when she suffered three broken ribs during a treatment, the chiropractor defendant claimed that the patient was claiming medical negligence by pointing to her injury rather than showing that the chiropractor was negligent or that the chiropractor’s alleged negligence caused her injury.
-
Falls in Older Adults
Falls cause significant morbidity and mortality among older adult patients compared to younger patients. When treating a patient who has fallen, the emergency medicine physician should identify traumatic injuries and evaluate for medical pathology contributing to the fall, as well as manage the patient.
-
New Jersey Appellate Court Affirms Dismissal of Complaint After Failure to Offer an Affidavit of Merit in Both Specialties of Treating Physician
Recently, a New Jersey appellate court affirmed a trial court’s dismissal of a medical malpractice plaintiff’s complaint for lacking an affidavit of merit, which often is a requirement in malpractice suits. The appeal of the trial court’s decision revolved around the sufficiency of an affidavit of merit in a situation where a defendant physician’s answer to the medical negligence complaint stated involvement in two specialties, but the plaintiff provided an affidavit of merit from a physician board-certified in only one of those specialties.
-
Is Text Messaging Ever HIPAA-Compliant?
Text messaging is so convenient and common that it is tempting to use it for communicating with patients. But HIPAA applies, and the use of text messaging is allowed only when meeting some strict requirements.
-
Patient Termination Requires Right Steps, Good Documentation
Terminating a relationship with a patient or banning someone from a hospital is never done lightly, and, fortunately, it does not happen often. But when it is necessary, healthcare organizations must tread carefully to ensure that the patient is afforded other opportunities and that the potential liabilities are minimized.
-
Patient Advocacy System Shown to Lower Malpractice Costs
A patient advocacy reporting program at Vanderbilt University Medical Center was associated with a significant decrease in malpractice claim costs for high-risk clinicians in an orthopedic practice network, suggesting a strategy that other hospitals can employ.
-
HITECH Audits Return: OCR Promises Enforcement Changes for HIPAA
The Health and Human Services Office for Civil Rights (HHS OCR) has reopened the Health Information Technology for Economic and Clinical Health (HITECH) audit program and will begin audits of HIPAA-regulated entities later in 2024. The audits will focus on the Security Rule, particularly the requirements for security risk analyses and risk management.
-
Disorders of Immunity Are a Risk Factor for Herpes Simplex Virus Encephalitis
The current study of herpes simplex virus (HSV) encephalitis demonstrated an association of encephalitis with preexisting autoimmune disease and/or exposure to immunosuppressive and immunomodulatory medications. The findings underscore the potential underestimation of antecedent immune-related dysregulation in HSV encephalitis cases to date.
-
Efgartigimod for Seronegative Myasthenia Gravis
In an uncontrolled, open-label series of patients with myasthenia gravis, double antibody-negative patients responded to immunosuppressive therapies in a similar manner as do those with antibodies to acetylcholine receptors (AChR) or muscle-specific tyrosine kinase. However, when treating myasthenia patients with a specific agent (efgartigimod) that blocks AChR antibodies at the level of endothelial cells, double antibody-negative patients do not respond as well.